Militia Capital Partners’s CorMedix CRMD Stock Holding History

Militia Capital Partners’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100,000	Closed	-$1.23M	–	189
2025 Q2	$1.23M	Buy	+100,000	New	+$1.1M	0.57%	46

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Militia Capital Partners's CRMD Position: Q3 2025 in Review

Militia Capital Partners sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 100,000 shares — an estimated $1.23M sold.

Militia Capital Partners first reported a position in CRMD in Q2 2025 and held it in 1 quarter. The position peaked at $1.23M in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

Militia Capital Partners reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
Militia Capital Partners sold 100,000 CorMedix shares in Q3 2025, an estimated $1.23M.
Militia Capital Partners first reported a position in CorMedix in Q2 2025 and held it in 1 quarter.
Militia Capital Partners's CorMedix position peaked at $1.23M in Q2 2025.
190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on Militia Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.